IMVT Stock Analysis: Buy, Sell, or Hold?
IMVT - Immunovant, Inc. Common Stock
$38.44
0.34 (0.89%)
▲
5d:
+14.95%
30d:
+12.63%
90d:
+57.67%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Smart Money Distribution
None View Scanner →
Strength: 8.0/10
Get Alerted When IMVT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: IMVT is 9.7% above its trading range ($35.05). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: IMVT is 9.7% above its trading range ($35.05). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: IMVT is currently trading at $38.44, which is considered extended relative to its 30-day fair value range of $29.65 to $35.05.
Technical Outlook: Technically, IMVT is in a uptrend. The price is approaching resistance at $38.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IMVT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $45.76 (+20.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IMVT is in a uptrend. The price is approaching resistance at $38.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IMVT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $45.76 (+20.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$29.65 -
$35.05
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
IMVT is technically overbought (RSI 72). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+9.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.1% below Wall St target ($45.76)
Trading Range Analysis
30-Day Trading Range
$29.65 -
$35.05
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$30.24
Resistance Level
$38.74
Current Trend
Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.75
Wall Street Target
$45.76
(+20.1%)
Share & Embed Analysis
Last updated: June 23, 2026 10:39 AM ET
Data refreshes hourly during market hours. Next update: 11:39 AM
Data refreshes hourly during market hours. Next update: 11:39 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IMVT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Tiago Girao
SELL
25760 shares
2026-04-23
Jay S Stout
SELL
2754 shares
2026-04-23
Jay S Stout
SELL
10132 shares
2026-04-08
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 58 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$105 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 61 BUY |
Advanced IMVT Option Strategies
Professional options setups generated by AI based on today's IMVT price and gamma walls.
